Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Cell Death & Disease|April 12, 2025
Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patientsLuisa Amato, Caterina De Rosa, Gaetano Di Guida, et al.
Oncotarget|May 13, 2015
AXL is an oncotarget in human colorectal cancerErika Martinelli, Giulia Martini, Claudia Cardone, et al.
International Journal of Cancer|April 16, 2022
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumabGiulia Martini, Davide Ciardiello, Marcello Dallio, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 7, 2021
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancerPietro Paolo Vitiello, Giulia Martini, Luigi Mele, et al.
Pageof 16